Interestingly, its morphology is more epithelial (Figure 1B) and its growth rate slower than PEO1, suggesting an epithelial-like subpopulation acquired a novel BRCA2 mutation that allowed it to outcompete a faster-growing but drug-responsive majority of tumor cells. The gene discussed is BRCA2; the disease is neoplasm.